Evaluation of pharmacological induction of fatty acid β-oxidation in X-linked adrenoleukodystrophy

Molecular Genetics and Metabolism

Volumn 74, Issue 1-2, 2001, Pages 256-263

  McGuinness, M C ^a   Zhang, H P ^a   Smith, K D ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fatty acid oxidation; Pharmacological agents; Therapy; X linked adrenoleukodystrophy

Indexed keywords

4 PHENYLBUTYRIC ACID; ABC TRANSPORTER; ACETIC ACID DERIVATIVE; AZACITIDINE; CHOLESTEROL; FATTY ACID; HYDROXYUREA; ISOBUTYRIC ACID; MEVINOLIN; PROTEIN; RNA; SIMVASTATIN; TRICHOSTATIN A; VERY LONG CHAIN FATTY ACID; ZAPRINAST;

ADRENOLEUKODYSTROPHY; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FATTY ACID OXIDATION; GENE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0034798513     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.2001.3239     Document Type: Article

References (50)

1. The neurobiology of X-linked adrenoleukodystrophy, a demyelinating peroxisomal disorder
2. Adrenoleukodystrophy: Incidence, new mutation rate, and results of extended family screening
3. X-linked adrenoleukodystrophy
4. Adrenoleukodystrophy: Impaired oxidation of very long chain fatty acids in white blood cells, cultured skin fibroblasts and amniocytes
5. Accumulation and defective β-oxidation of very long-chain fatty acids in Zellweger's syndrome, adrenoleukodystrophy and Refsum's disease variants
6. Lignoceric acid is oxidized in the peroxisomes: Implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy
7. X-linked adrenoleukodystrophy: Defective peroxisomal oxidation of very long chain fatty acids but not of very long chain fatty acyl-CoA esters
8. Adrenoleukodystrophy: Impaired oxidation of fatty acids due to peroxisomal lignoceroyl-CoA ligase deficiency
9. Direct demonstration that the deficient oxidation of very long-chain fatty acids in X-linked adrenoleukodystrophy is due to an impaired ability of peroxisomes to activate very long-chain fatty acids
10. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters
11. Purification and properties of rat liver peroxisomal very long chain Acyl-CoA synthetase
12. Molecular cloning of cDNA encoding rat very long chain acyl-CoA synthetase
13. Long-term effect of bone marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy
14. Reversal of early neurologic and neuroradiologic manifestation of X-linked adrenoleukodystrophy by bone marrow transplantation
15. The future for treatment by bone marrow transplantation for adrenoleukodystrophy, metachromaic leukodystrophy, globoid cell leukodystrophy and Hurler syndrome
16. A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy
17. Adrenoleukodystrophy: Oleic acid lowers fibroblast saturated C22-C26 fatty acids
18. Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil"
19. Very long chain fatty acids in X-linked adrenoleukodystrophy brain after treatment with Lorenzo's oil
20. Brain, liver, and adipose tissue erucic and very long chain fatty acid levels in adrenoleukodystrophy patients treated with glyceryl-trierucate and trioleate oils (Lorenzo's oil)
21. Retroviral transfer and long-term expression of the adrenoleukodystrophy gene in human CD34+ cells
22. Lovastatin and sodium phenylacetate normalize the levels of very long chain fatty acids in skin fibroblasts of X-adrenoleukodystrophy
23. Lovastatin therapy for X-linked adrenoleukodystrophy: Clinical and biochemical observations on 12 patients
24. Lovastatin does not correct the accumulation of very long-chain fatty acids in tissues of adrenoleukodystrophy protein-deficient mice
25. Simvastatin does not normalize very long chain fatty acids in adrenoleukodystrophy mice
26. Gene redundancy and pharmacological gene therapy: Implications for X-linked Adrenoleukodystrophy
27. Pharmacologic induction of peroxisomes in peroxisome biogenesis disorders
28. A mouse model for X-linked adrenoleukodystrophy
29. Urea cycle disorders: Diagnosis, pathophysiology, and therapy
30. Short-chain fatty acids inhibit intestinal trefoil factor gene expression in colon cancer cells
31. Different accessibilities in chromatin to histone acetylase
32. Induction of histone acetylation and growth regulation in eryrthroleukemia cells by 4-phenybutyrate and structural analogs
33. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A
34. Trichostatin A and trapoxin: Novel chemical probes for the role of histone acetylation in chromatin structure and function
35. Phosphodiesterase 5 inhibitors and nitrergic transmission - From zaprinast to sildenafil
36. Mechanism of action of hydroxyurea
37. Effects of 5-azacytidine and its 2′-deoxyderivative on cell differentiation and DNA methylation
38. Fetal hemoglobin in sickle cell anemia: Determinants of response to hydroxyurea. Multicenter Study of Hydroxyurea
39. Clinical and hematological responses to hydroxyurea in Sicilian patients with Hb S/beta-thalessemia
40. Brief report: Treatment with azacytidine of patients with end-stage beta-thalassemia
41. Oral sodium phenylbutyrate therapy in homozygous beta-thalassemia: A clinical trial
42. Mechanism of action and biological profile of HMG CoA reductase inhibitors
43. Peroxisomal fatty acid β-oxidation in HepG2 cells
44. Phytanic acid alpha-oxidation in rat liver: Requirement of cytosolic factor
45. Peroxisomal lignoceroyl-CoA ligase deficiency in childhood adrenoleukodystrophy and adrenomyeloneuropathy
46. Molecular and functional characterization of the murine glucocereboside gene
47. Transcriptional regulation of the human placental-like alkaline phosphatase gene and mechanisms involved in its induction by sodium butyrate
48. Two cytotoxic cell proteinase genes are differentially sensitive to sodium butyrate
49. Transcriptional upregulation of TGF-alpha by phenylacetate and phenylbutyrate is associated with differentiation of human melanoma cells
50. Long-term treatment of girls with ornithine transcarbamylase deficiency